Drug Discovery - Introducing the Clara™ System for Clarity in Biologics Preparations
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

Mastering Optimal Plate Reader AssaysMastering Optimal Plate Reader Assays

Looking to generate more reliable results while reducing assay development time? Explore this eBook to discover optimised assay workflows for common drug discovery applications and learn how validated solutions can help improve reproducibility, efficiency, and confidence in your research outcomes.

Free eBook Download Now
 
 
    Introducing the Clara™ System for Clarity in Biologics PreparationsIntroducing the Clara™ System for Clarity in Biologics Preparations
 
The complexity of biological molecules introduces a number of challenges for the development of monoclonal antibodies (MABs). The antibody discovery and protein engineering pathway for the design of MABs for therapeutic applications is particularly demanding. The Clara™ filter system provides solution for mid-volume cell culture during scale up allowing fast and simple cell clarification and protein purification of up to 50 mL cultured cells per well in a 6 well format.
Find Solution Here
 
 
   Origami-Inspired Capsule Shows Promise for Multi-Day Dosing and Sustained Drug ReleaseOrigami-Inspired Capsule Shows Promise for Multi-Day Dosing and Sustained Drug Release
 
An innovative origami-inspired capsule designed by MIT offers extended drug release, improving treatment efficacy and reducing preventable healthcare costs.		 
   Study identifies a novel direct drug target for head and neck squamous cell carcinomaStudy identifies a novel direct drug target for head and neck squamous cell carcinoma
 
Chemotherapy remains a cornerstone of treatment for head and neck cancers, the seventh-most common cancer type worldwide.		 
   Study reveals hidden myxobacteria diversity for future drug discoveryStudy reveals hidden myxobacteria diversity for future drug discovery
 
Most antibiotics used clinically are based on natural compounds produced by bacteria and other microorganisms.		 
   AI Models Zero In on Antibody Binding Regions to Improve Drug Target PredictionsAI Models Zero In on Antibody Binding Regions to Improve Drug Target Predictions
 
Focusing on complementarity-determining regions in antibody models leads to better binding affinity predictions, potentially accelerating treatment discovery.		 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026